Oncogene - Table of Contents alert Volume 32 Issue 27

TABLE OF CONTENTS
Volume 32, Issue 27 (July 2013)
	In this issue Review Original Articles Short Communication Also new AOP	Sign up for e-alerts Recommend to your library Web feed Subscribe
Advertisement
Naturejobs presents the: Naturejobs Career Expo September 19, 2013 The Business Design Centre, London, UK Click here for more information or to register for this conference today!
Review		Top
Rejuvenating Bi(d)ology S S Zinkel, X M Yin and A Gross Oncogene 2013 32: 3213-3219; advance online publication, October 15, 2012; 10.1038/onc.2012.454 Abstract | Full Text
Original Articles		Top
Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression A Ben-Shmuel, A Shvab, N Gavert, T Brabletz and A Ben-Ze'ev Oncogene 2013 32: 3220-3230; advance online publication, August 6, 2012; 10.1038/onc.2012.340 Abstract | Full Text
Bach1 is critical for the transformation of mouse embryonic fibroblasts by RasV12 and maintains ERK signaling A Nakanome, A Brydun, M Matsumoto, K Ota, R Funayama, K Nakayama, M Ono, K Shiga, T Kobayashi and K Igarashi Oncogene 2013 32: 3231-3245; advance online publication, July 30, 2012; 10.1038/onc.2012.336 Abstract | Full Text
Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility O Aprelikova, J Palla, B Hibler, X Yu, Y E Greer, M Yi, R Stephens, G L Maxwell, A Jazaeri, J I Risinger, J S Rubin and J Niederhuber Oncogene 2013 32: 3246-3253; advance online publication, August 13, 2012; 10.1038/onc.2012.351 Abstract | Full Text
The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling K Sully, O Akinduro, M P Philpott, A S Naeem, C A Harwood, V E Reeve, R F O'Shaughnessy and C Byrne Oncogene 2013 32: 3254-3262; advance online publication, August 13, 2012; 10.1038/onc.2012.338 Abstract | Full Text
RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex B A Abhari, S Cristofanon, R Kappler, D von Schweinitz, R Humphreys and S Fulda Oncogene 2013 32: 3263-3273; advance online publication, August 13, 2012; 10.1038/onc.2012.337 Abstract | Full Text
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer M Razandi, A Pedram, V C Jordan, S Fuqua and E R Levin Oncogene 2013 32: 3274-3285; advance online publication, August 20, 2012; 10.1038/onc.2012.335 Abstract | Full Text
Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis Open P Dong, M Karaayvaz, N Jia, M Kaneuchi, J Hamada, H Watari, S Sudo, J Ju and N Sakuragi Oncogene 2013 32: 3286-3295; advance online publication, July 30, 2012; 10.1038/onc.2012.334 Abstract | Full Text
HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma X Qiu, S Dong, F Qiao, S Lu, Y Song, Y Lao, Y Li, T Zeng, J Hu, L Zhang, L Zhang and H Fan Oncogene 2013 32: 3296-3305; advance online publication, April 22, 2013; 10.1038/onc.2013.150 Abstract | Full Text
Short Communication		Top
miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling C A Gebeshuber and J Martinez Oncogene 2013 32: 3306-3310; advance online publication, August 27, 2012; 10.1038/onc.2012.372 Abstract | Full Text
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com